# TuHURA BIOSCIENCES, INC./NV (HURA) · Edgar & Edgarette company card

> TuHURA BIOSCIENCES (HURA) reported revenue of $0 million in FY2025, equity 76.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1498382 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HURA) · [JSON](https://www.pops4.com/boards/company/HURA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | -Infinity% |
| Operating cash flow | −$28M |
| Capital spending | $76,083 |
| Free cash flow | −$28M |
| Cash | $4M |
| Long-term debt | — |
| Total assets | $27M |
| Total equity | $21M |
| Equity ÷ assets | 76.5% |
| Return on equity | -143.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Sound ship · one warning sign · operating cash flow was negative (-$27.6M in FY2025)

## Edgarette's reading

Exposure: revenue $0K (FY2025). Experience: one year on record. Soundness: equity 76.5% of assets, return on equity -143.6%. Credibility: four or more audited years, reasonable weight.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-01-30 ([filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/0001193125-26-031742-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-09-16 ([filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526393206/0001193125-26-393206-index.htm))

## Recent filings

- 8-K · filed 2026-10-16 · 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/0001193125-26-424228-index.htm)
- 8-K · filed 2026-09-24 · 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526401140/0001193125-26-401140-index.htm)
- 8-K · filed 2026-09-17 · 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526394473/0001193125-26-394473-index.htm)
- 8-K · filed 2026-09-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526393206/0001193125-26-393206-index.htm)
- 8-K · filed 2026-09-04 · 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526383797/0001193125-26-383797-index.htm)
- 8-K · filed 2026-08-21 · 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1498382/000119312526361272/0001193125-26-361272-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001498382.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1498382

## Cite

POPS4, Edgar & Edgarette: TuHURA BIOSCIENCES, INC./NV (HURA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/HURA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.